[1]
P. Kaloyannidis, E. Al Shaibani, A. Moinnudin, K. Al Anezi, and H. Al Hashmi, “Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach”, Hematol Rep, vol. 13, no. 1, Mar. 2021.